FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.72B
1-Year Est. Return 129.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+129.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.5B
AUM Growth
+$313M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$60.3M
2
+$31.5M
3
+$29.8M
4
EOLS icon
Evolus
EOLS
+$24.9M
5
CYTK icon
Cytokinetics
CYTK
+$19.3M

Top Sells

1
+$36M
2
+$35.7M
3
+$15.7M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$7.81M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$7.2M

Sector Composition

1 Healthcare 99.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$346M 13.83%
6,795,121
2
$320M 12.8%
3,383,950
-73,900
3
$301M 12.03%
16,607,074
+490,656
4
$164M 6.56%
3,800,457
5
$138M 5.54%
9,874,511
+1,089,227
6
$120M 4.78%
12,466,489
+2,357,210
7
$94.6M 3.78%
688,460
8
$87.6M 3.5%
1,654,834
-100,000
9
$68.3M 2.73%
5,985,347
10
$56.6M 2.26%
1,397,527
11
$56.1M 2.24%
10,259,409
12
$56M 2.24%
4,567,275
+438,274
13
$55.3M 2.21%
4,887,867
14
$45.7M 1.83%
1,308,138
+958,138
15
$42.6M 1.7%
1,279,754
+209,900
16
$36.7M 1.47%
997,455
17
$35.8M 1.43%
983,715
+325,000
18
$31.9M 1.28%
+5,100,000
19
$28.9M 1.15%
22,729,436
+153,585
20
$28.6M 1.14%
1,000,647
+399,518
21
$26.1M 1.05%
11,462,301
22
$25.6M 1.02%
9,440,112
+1,620,249
23
$23M 0.92%
133,333
24
$22.4M 0.9%
+2,435,550
25
$21.1M 0.84%
10,617,062
1
2 3